Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Electroencephalography Devices Market, by Type
1.4.2 Europe Electroencephalography Devices Market, by End User
1.4.3 Europe Electroencephalography Devices Market, by Product
1.4.4 Europe Electroencephalography Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Electroencephalography Devices Market
Chapter 4. Europe Electroencephalography Devices Market by Type
4.1 Europe Standalone Market by Country
4.2 Europe Portable Market by Country
Chapter 5. Europe Electroencephalography Devices Market by End-use
5.1 Europe Hospitals Market by Country
5.2 Europe Diagnostic Centers Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Electroencephalography Devices Market by Product
6.1 Europe 32-channel Market by Country
6.2 Europe 25-channel Market by Country
6.3 Europe 40-channel Market by Country
6.4 Europe 21-channel Market by Country
6.5 Europe 8-channel Market by Country
6.6 Europe Multichannel Market by Country
Chapter 7. Europe Electroencephalography Devices Market by Country
7.1 Germany Electroencephalography Devices Market
7.1.1 Germany Electroencephalography Devices Market by Type
7.1.2 Germany Electroencephalography Devices Market by End-use
7.1.3 Germany Electroencephalography Devices Market by Product
7.2 UK Electroencephalography Devices Market
7.2.1 UK Electroencephalography Devices Market by Type
7.2.2 UK Electroencephalography Devices Market by End-use
7.2.3 UK Electroencephalography Devices Market by Product
7.3 France Electroencephalography Devices Market
7.3.1 France Electroencephalography Devices Market by Type
7.3.2 France Electroencephalography Devices Market by End-use
7.3.3 France Electroencephalography Devices Market by Product
7.4 Russia Electroencephalography Devices Market
7.4.1 Russia Electroencephalography Devices Market by Type
7.4.2 Russia Electroencephalography Devices Market by End-use
7.4.3 Russia Electroencephalography Devices Market by Product
7.5 Spain Electroencephalography Devices Market
7.5.1 Spain Electroencephalography Devices Market by Type
7.5.2 Spain Electroencephalography Devices Market by End-use
7.5.3 Spain Electroencephalography Devices Market by Product
7.6 Italy Electroencephalography Devices Market
7.6.1 Italy Electroencephalography Devices Market by Type
7.6.2 Italy Electroencephalography Devices Market by End-use
7.6.3 Italy Electroencephalography Devices Market by Product
7.7 Rest of Europe Electroencephalography Devices Market
7.7.1 Rest of Europe Electroencephalography Devices Market by Type
7.7.2 Rest of Europe Electroencephalography Devices Market by End-use
7.7.3 Rest of Europe Electroencephalography Devices Market by Product
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Approvals and Trials:
8.1.6 SWOT Analysis
8.2 Compumedics Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals and Trials:
8.3 Natus Medical Incorporated (Archimed SAS)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.4 Nihon Kohden Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Product Category and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Product Launches and Product Expansions:
8.5 Cadwell Industries, Inc.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Acquisition and Mergers:
8.6 Neurowave Systems, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Approvals and Trials:
8.7 Magstim EGI (Magstim, Inc.)
8.7.1 Company Overview
8.8 Noraxon U.S.A. Inc.
8.8.1 Company Overview
Unique Offerings 
